tiprankstipranks
Trending News
More News >
PhoenixBio Co., Ltd. (JP:6190)
:6190
Japanese Market

PhoenixBio Co., Ltd. (6190) Financial Statements

Compare
0 Followers

PhoenixBio Co., Ltd. Financial Overview

PhoenixBio Co., Ltd.'s market cap is currently ¥2.05B. The company's EPS TTM is ¥-1.71; its P/E ratio is -6.52; PhoenixBio Co., Ltd. is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 1.54B¥ 1.72B¥ 2.12B¥ 1.32B¥ 1.01B
Gross Profit¥ 1.11B¥ 1.20B¥ 1.56B¥ 727.79M¥ 588.14M
Operating Income¥ -135.17M¥ 11.06M¥ 508.45M¥ -167.62M¥ -276.89M
EBITDA¥ -396.12M¥ 87.94M¥ 537.42M¥ -305.81M¥ -167.27M
Net Income¥ -445.65M¥ 26.38M¥ 493.33M¥ -387.97M¥ -238.00M
Balance Sheet
Cash & Short-Term Investments¥ 1.15B¥ 1.39B¥ 1.56B¥ 1.33B¥ 1.33B
Total Assets¥ 2.29B¥ 2.72B¥ 3.02B¥ 2.28B¥ 2.52B
Total Debt¥ 565.36M¥ 723.93M¥ 1.13B¥ 1.07B¥ 1.04B
Net Debt¥ -584.03M¥ -660.96M¥ -425.35M¥ -256.59M¥ -289.12M
Total Liabilities¥ 919.92M¥ 917.71M¥ 1.50B¥ 1.45B¥ 1.42B
Stockholders' Equity¥ 1.37B¥ 1.80B¥ 1.51B¥ 828.15M¥ 1.09B
Cash Flow
Free Cash Flow¥ -94.24M¥ -118.08M¥ 265.12M¥ 9.63M¥ -284.23M
Operating Cash Flow¥ -73.00M¥ -79.31M¥ 277.49M¥ 16.40M¥ -101.91M
Investing Cash Flow¥ -27.98M¥ 115.36M¥ -156.34M¥ -6.97M¥ -184.78M
Financing Cash Flow¥ -128.00M¥ -244.88M¥ 86.63M¥ -34.66M¥ -160.19M
Currency in JPY

PhoenixBio Co., Ltd. Earnings and Revenue History

PhoenixBio Co., Ltd. Debt to Assets

PhoenixBio Co., Ltd. Cash Flow

PhoenixBio Co., Ltd. Forecast EPS vs Actual EPS